Yujun Wei
Changhongjie, 300071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial.
Journal: Frontiers in immunology
Published: March 01, 2026
Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.
Journal: Leukemia & lymphoma
Published: January 05, 2026
Editorial Expression of Concern: Chitosan/silk fibroin-based tissue-engineered graft seeded with adipose-derived stem cells enhances nerve regeneration.
Journal: Journal of materials science. Materials in medicine
Published: November 06, 2025
Overexpression of Sterol Regulatory Element-binding Transcription Factor 2 is associated with an adverse prognosis in cytogenetically normal acute myeloid leukemia.
Journal: Discover oncology
Published: May 29, 2025
Low-dose ruxolitinib as first-line therapy for acute graft-versus-host disease (aGVHD) increases the risk of Epstein-Barr virus (EBV) reactivation but not posttransplant lymphoproliferative disease (PTLD).
Journal: Cancer pathogenesis and therapy
Published: April 21, 2025
Ruxolitinib and decitabine plus a busulfan-cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes.
Journal: Frontiers in immunology
Published: March 03, 2025
Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study.
Journal: Annals of hematology
Published: January 14, 2024
Effects of microRNA-338 Transfection into Sciatic Nerve on Rats with Experimental Autoimmune Neuritis.
Journal: Journal of molecular neuroscience : MN
Published: May 20, 2020
Lentiviral vectors enveloped with rabies virus glycoprotein can be used as a novel retrograde tracer to assess nerve recovery in rat sciatic nerve injury models.
Journal: Cell and tissue research
Published: July 04, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026